Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/120507
Full metadata record
DC FieldValueLanguage
dc.creatorAssunção J.
dc.creatorCatarina Guedes A.
dc.creatorXavier Malcata F.
dc.date.accessioned2019-05-31T16:16:32Z-
dc.date.available2019-05-31T16:16:32Z-
dc.date.issued2017
dc.identifier.issn16603397
dc.identifier.urihttps://hdl.handle.net/10216/120507-
dc.description.abstractThe long-lasting interest in bioactive molecules (namely toxins) produced by (microalga) dinoflagellates has risen in recent years. Exhibiting wide diversity and complexity, said compounds are well-recognized for their biological features, with great potential for use as pharmaceutical therapies and biological research probes. Unfortunately, provision of those compounds is still far from sufficient, especially in view of an increasing demand for preclinical testing. Despite the difficulties to establish dinoflagellate cultures and obtain reasonable productivities of such compounds, intensive research has permitted a number of advances in the field. This paper accordingly reviews the characteristics of some of the most important biotoxins (and other bioactive substances) produced by dinoflagellates. It also presents and discusses (to some length) the main advances pertaining to dinoflagellate production, from bench to large scale—with an emphasis on material published since the latest review available on the subject. Such advances encompass improvements in nutrient formulation and light supply as major operational conditions; they have permitted adaptation of classical designs, and aided the development of novel configurations for dinoflagellate growth—even though shearing-related issues remain a major challenge. © 2017 by the authors.
dc.description.sponsorshipThis work was financially supported by: Project DINOSSAUR—PTDC/BBB-EBB/ 1374/2014-POCI-01-0145-FEDER-016640, funded by FEDER funds through COMPETE2020—Programa Operacional Competitividade e Internacionaliza ão (POCI), and by national funds through FCT—Funda ão para a Ciência e a Tecnologia, I.P. A postdoctoral fellowship (ref. SFRH/BPD/72777/2010) for author A.C.G., supervised by author F.X.M., was granted by Funda ão para a Ciência e Tecnologia (FCT, Portugal, Lisbon), under the auspices of ESF and Portuguese funds (MEC). This research was also partially supported by POCI-01-0145-FEDER-006939 (Laboratory for Process Engineering, Environment, Biotechnology and Energy—UID/EQU/00511/2013), funded by the European Regional Development Fund (ERDF), through COMPETE2020—Programa Operacional Competitividade e Internacionaliza ão (POCI) and by national funds via FCT, through project NORTE-01-0145-FEDER-000005—LEPABE-2-ECO-INNOVATION, supported by North Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofMarine Drugs, vol. 15(12):393
dc.rightsopenAccess
dc.subjectalgal cell culture
dc.subjectdinoflagellate
dc.subjecthuman
dc.subjectmicroalga
dc.subjectnonhuman
dc.subjectnutrient
dc.subjectproductivity
dc.titleBiotechnological and pharmacological applications of biotoxins and other bioactive molecules from dinoflagellates
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoCIIMAR - Centro Interdisciplinar de Investigação Marinha e Ambiental
dc.identifier.doi10.3390/md15120393
dc.relation.publisherversionhttp://dx.doi.org/10.3390/md15120393
Appears in Collections:CIIMAR - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Assuncao J_2017.pdf4.79 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.